Percutaneous treatment of multiple fistulas associated with a giant aneurysm
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30570
Abstract: Coronary fistulas are not common in patients undergo coronary angiography. It is described, even less frequently, that coronary fistulas may be associated with giant aneurysms along their course. These cases classically are treated surgically. We… read more here.
Keywords: percutaneous treatment; fistulas associated; associated giant; treatment multiple ... See more keywords
Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Hematology"
DOI: 10.1007/s00277-022-04775-1
Abstract: Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) can be late complications following mutagenic treatment. Limited data is available on the outcome of patients developing therapy-related MDS and AML after treatment for multiple myeloma (MM).… read more here.
Keywords: therapy related; mds; myeloma; treatment multiple ... See more keywords
Surgical treatment of multiple coronary-to-pulmonary artery fistulas with severe coronary artery stenosis
Sign Up to like & getrecommendations! Published in 2019 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-019-01118-2
Abstract: A coronary artery fistula (CAF) is an abnormal connection between a coronary artery and a cardiac chamber or a great vessel. CAF draining into the main pulmonary artery, called coronary-to-pulmonary artery fistula (CPAF), is one… read more here.
Keywords: treatment multiple; coronary pulmonary; surgical treatment; artery ... See more keywords
Immunotherapy for the treatment of multiple myeloma.
Sign Up to like & getrecommendations! Published in 2017 at "Critical reviews in oncology/hematology"
DOI: 10.1016/j.critrevonc.2017.01.011
Abstract: Immunotherapy has recently emerged as a promising treatment for multiple myeloma (MM). There are now several monoclonal antibodies that target specific surface antigens on myeloma cells or the checkpoints of immune and myeloma cells. Elotuzumab… read more here.
Keywords: treatment multiple; immunotherapy; immunotherapy treatment; treatment ... See more keywords
Endovascular treatment for multiple aortic narrowings in a patient with Takayasu arteritis.
Sign Up to like & getrecommendations! Published in 2019 at "Presse medicale"
DOI: 10.1016/j.lpm.2018.11.026
Abstract: A 17-year-old girl with a 1-month history of Takayasu arteritis had been referred for treatment of multiple stenotic lesions of the descending and abdominal aorta (figure 1A) and associated arterial hypertension (170/100 mmHg). She had… read more here.
Keywords: treatment multiple; figure; takayasu arteritis;
A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Sign Up to like & getrecommendations! Published in 2018 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2017.11.014
Abstract: The authors report a case of a 69-year-old woman with multiple sclerosis treated with fingolimod for duration of over one year who subsequently developed cutaneous large B cell lymphoma. There are few reported cases of… read more here.
Keywords: treatment multiple; sclerosis; multiple sclerosis; large cell ... See more keywords
B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2019.07.016
Abstract: Secondary autoimmune disorders (AID) are a recognised complication of alemtuzumab treatment for multiple sclerosis. We have previously reported two female multiple sclerosis patients treated with alemtuzumab who developed rare but severe secondary AID; acquired haemophilia… read more here.
Keywords: treatment multiple; alemtuzumab treatment; treatment; multiple sclerosis ... See more keywords
Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma.
Sign Up to like & getrecommendations! Published in 2017 at "Seminars in oncology nursing"
DOI: 10.1016/j.soncn.2017.05.005
Abstract: OBJECTIVE To review the current evidence on the use of immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs) in the treatment of multiple myeloma (MM). DATA SOURCES Journal articles, research reports, state of the science papers,… read more here.
Keywords: treatment multiple; proteasome inhibitors; treatment; multiple myeloma ... See more keywords
Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01979
Abstract: The sphingosine-1-phosphate-1 (S1P1) receptor agonists have great potential for the treatment of multiple sclerosis (MS) because they can inhibit lymphocyte egress through receptor internalization. We designed and synthesized triazole and isoxazoline derivatives to discover a… read more here.
Keywords: receptor agonists; treatment multiple; treatment; receptor ... See more keywords
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T-cells for treatment of multiple myeloma
Sign Up to like & getrecommendations! Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0951-5
Abstract: Chimeric antigen receptor (CAR) T-cell therapy remains limited to select centers that can carefully monitor adverse events. To broaden use of CAR T cells in community clinics and in a frontline setting, we developed a… read more here.
Keywords: treatment multiple; myeloma; multiple myeloma; car cells ... See more keywords
Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis
Sign Up to like & getrecommendations! Published in 2017 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2016.1178302
Abstract: ABSTRACT Purpose: To report the efficacy of mycophenolate mofetil (MMF) as adjunctive therapy for the treatment of multiple sclerosis (MS)-associated uveitis. Methods: In this retrospective, interventional case series, patients with MS-associated uveitis who were treated… read more here.
Keywords: treatment multiple; associated uveitis; sclerosis associated; treatment ... See more keywords